Xconomy: Alzheimer's disease News, Articles and Opinions

“alzheimers-disease” Archives

Entry	Author	Date	Location
Urovant Bladder Drug Hits Test Goals But Can’t Outpace Generic Rival	Frank Vinluan	03/19/19	San Diego
Voyager Therapeutics, AbbVie Add Parkinson’s to Gene Therapy Pact	Frank Vinluan	02/22/19	Boston
Alector IPO Banks $176M to Test Alzheimer’s Drugs in Clinical Trials	Frank Vinluan	02/06/19	San Francisco
FDA Rejects Alkermes Depression Drug, Asks for More Clinical Data	Frank Vinluan	02/01/19	Boston
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More	Frank Vinluan	02/01/19	National
All Eyes on Biogen as Roche Alzheimer’s Drug Flunks Final Test	Ben Fidler	01/30/19	National
Dewpoint Debuts with $60M to Target Protein Droplets Linked to Disease	Corie Lok	01/30/19	Boston
Bio Roundup: Aimmune Drama, Shutdown Blues, Perlmutter Talks Cancer	Ben Fidler	01/18/19	National
Tetra Inks Deal with Shionogi to Support Fragile X, Alzheimer’s R&D	Sarah Schmid Stevenson	01/09/19	Detroit Ann Arbor
Alector Files for IPO to Fund Studies of Alzheimer’s, Dementia Drugs	Frank Vinluan	01/07/19	San Francisco
San Francisco Biotech: The Next Generation—Photos and Takeaways	Frank Vinluan	12/26/18	San Francisco
Bio Roundup: 2019 Trials, Pilgrim Price Chat, Pre-Xmas Sales & More	Alex Lash	12/21/18	National
15 for ’19: Key Clinical Data to Watch for Next Year (Part 1)	Ben Fidler	12/17/18	National
Eli Lilly Partners with AC Immune on Tau Blockers for Alzheimer’s	Corie Lok	12/12/18	Indiana
Viracta, Neurelis & More: The Latest in San Diego Biotech	Sarah de Crescenzo	12/05/18	San Diego
Salk Team Awarded 8-Year, $19.2M Grant for Alzheimer’s Research	Sarah de Crescenzo	11/09/18	San Diego
Allogene, Cortexyme & RDMD Headline Xconomy’s Dec. 5 Biotech Forum	Frank Vinluan	11/08/18	San Francisco
Rainwater Foundation Deploys Millions Toward Rare Brain Disease, PSP	David Holley	11/07/18	Texas
Win $2 Million to Solve Alzheimer’s: New Prize Will Reward Fresh Ideas	David Holley	11/05/18	Texas
Sanofi Pledges $125M to Denali in Pact for Neuro, Inflammation Drugs	Frank Vinluan	11/01/18	San Francisco
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More	Frank Vinluan	10/26/18	National
Still Seeking Pharma Partner, Phoenix Bio Adds $1M in Angel Funding	David Holley	10/25/18	Texas
Swabbing DNA on Phones Reveals Mysteries of Microbial World Around Us	Jeff Buchanan	10/10/18	Wisconsin
Bio Roundup: An Alzheimer’s Head-Scratcher, OUTBio, GSK & Gilead Shakeups	Ben Fidler	07/27/18	National
Eisai & Biogen Reveal Promising Alzheimer’s Data, But Questions Linger	Frank Vinluan	07/26/18	Boston
Alector Snags $133M to Activate Immune Cells Against Neurodegeneration	Bernadette Tansey	07/25/18	San Francisco
Fresh Off Bristol Buyout, IFM Backers Raise $31M to Plot a Second Strike	Frank Vinluan	07/19/18	Boston
Bio Roundup: Pfizer’s Prices, Novartis Cuts, Gene Therapy Guide & More	Frank Vinluan	07/13/18	National
Biogen, Eisai Claim Success in New Analysis of Failed Alzheimer’s Study	Frank Vinluan	07/06/18	Boston
Lundbeck Reaches Across Atlantic, Picks Dunsire for CEO Post	Alex Lash	07/02/18	Boston
Page 1 of 5	next page »